Penn State Children’s Hospital is recruiting an outstanding clinical investigator for the position of Director, Clinical Research in Pediatric Cancer within the Four Diamonds Pediatric Cancer Research Center in the Division of Pediatric Hematology/Oncology at the Pennsylvania State University College of Medicine. This position is partially supported by Four Diamonds and THON, one of the largest student-run philanthropies in the US. The Four Diamonds Pediatric Cancer Research Center is supported by greater than $70M in endowment funds.
Division of Pediatric Hematology/Oncology
The Division has 14 Pediatric Hematologists/Oncologists and 12 Ph.D. faculty. Over 100 new oncology patients are seen annually, and there are programs in pediatric stem cell transplantation, experimental therapeutics, neuro-oncology, AYA oncology, and survivorship. The division has an accredited Pediatric Hem/Onc fellowship program and is an active member of COG, POETIC, and BCC. The Four Diamonds Pediatric Cancer Research Program consists of NIH-funded basic and translational research in childhood malignancies including leukemia, solid tumors, and brain tumors. Research is supported by the Penn State Cancer Institute, the Penn State Institute for Personalized Medicine, a NIH-funded CTSI, and Pediatric Clinical Trials Office. Basic core, translational, and clinical facilities provide an excellent environment for research.
The Four Diamonds Pediatric Oncology Research Center
The Four Diamonds Pediatric Oncology Research Center is supported by >$70M in research endowments developed from 1999 to the present. Currently, five principal investigators, all of whom are NIH funded, lead laboratory-based research designed to understand molecular pathways involved in pediatric cancer and develop new therapies, and the Pediatric Oncology Experimental Therapeutics Program provides the infrastructure for participation in leading Phase I and II clinical research consortium. Major initiatives planned in the next five years include: 1) the design and development of a new Innovation Pavilion for research and education; 2) development of a new Epigenetics and Gene Regulation Research program; 3) development of a new pediatric oncology immunotherapy and cellular therapeutics program; and 4) to enhance interaction of the Four Diamonds Pediatric Oncology Research Center laboratories with each other and with the Penn State Cancer Institute.
Successful applicants will have an M.D./Ph.D. or M.D. degree with an established track record in cancer research and demonstrated the ability to develop investigator-initiated clinical research trials. This individual should be a nationally established research leader with a highly visible role in COG/clinical consortium. Rank is at the Associate to Full Professor level commensurate with the applicant’s experience and accomplishments.
In concert with the Chief of the Division of Pediatric Hematology/Oncology, the search process is being led by Zack Reynolds, Managing Director of Diversified Search. Nominations and expressions of interest should be directed to Zack at 773-454-7961, or by email at: PSHChildrens@divsearch.com